Massimo Terzolo

Active 1994–2025

114
Papers
18,509
Citations
74
h-index
109
i10-index

Citations

Citations per year for Massimo Terzolo1973: 1 citations1977: 1 citations1992: 1 citations1995: 2 citations1997: 4 citations1998: 8 citations1999: 8 citations2000: 29 citations2001: 21 citations2002: 22 citations2003: 30 citations2004: 30 citations2005: 41 citations2006: 41 citations2007: 32 citations2008: 59 citations2009: 96 citations2010: 77 citations2011: 120 citations2012: 119 citations2013: 111 citations2014: 84 citations2015: 140 citations2016: 78 citations2017: 103 citations2018: 124 citations2019: 534 citations2020: 695 citations2021: 554 citations2022: 446 citations2023: 337 citations2024: 594 citations2025: 304 citations2026: 13 citations1974–1976: no citations, so these years are not shown1978–1991: no citations, so these years are not shown1993–1994: no citations, so these years are not shown1996: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 742 citing papers, 19.3% of this breakdownItaly: 473 citing papers, 12.3% of this breakdownGermany: 343 citing papers, 8.9% of this breakdownUnited Kingdom: 273 citing papers, 7.1% of this breakdownFrance: 238 citing papers, 6.2% of this breakdownChina: 189 citing papers, 4.9% of this breakdownNetherlands: 188 citing papers, 4.9% of this breakdownCanada: 106 citing papers, 2.7% of this breakdownSpain: 103 citing papers, 2.7% of this breakdownAustralia: 99 citing papers, 2.6% of this breakdownSwitzerland: 94 citing papers, 2.4% of this breakdownBrazil: 81 citing papers, 2.1% of this breakdown
0%19.3%Other 23.9%

Fields

  • Medicine88.6%
  • Biochemistry, Genetics and Molecular Biology6.5%
  • Computer Science1.5%
  • Engineering1%
  • Neuroscience0.9%
  • Pharmacology, Toxicology and Pharmaceutics0.4%
  • Other1.1%

Topics

  • Adrenal and Paraganglionic Tumors20.4%
  • Pituitary Gland Disorders and Treatments14.1%
  • Hormonal Regulation and Hypertension11.6%
  • Adrenal Hormones and Disorders7%
  • Cancer, Hypoxia, and Metabolism6.4%
  • Growth Hormone and Insulin-like Growth Factors3.1%
  • Other37.4%

Coauthors

All papers

Open in search
  1. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors

    Authors: , , , , , , , , , , , - European Journal of Endocrinology 2023 cited by 665

  2. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors

    Authors: , , , , , , , , , - European Journal of Endocrinology 2016 cited by 1,549

  3. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors

    Authors: , , , , , , , , , - European Journal of Endocrinology 2018 cited by 941

  4. Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , - Annals of Oncology 2020 cited by 420

  5. Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dimitris Margaritopoulos, Tina Dušek, Roberta Maggio, Carla Scaroni, Antonio Concistrè, Cristina L. Ronchi, Barbara Altieri, Cristina Mosconi, Aristidis Diamantopoulos, Nicole M. Iñiguez‐Ariza, Valentina Vicennati, Anna Pia, Matthias Kroiß, Gregory Kaltsas, Alexandra Chrisoulidou, Ljiljana Marina, Valentina Morelli, Wiebke Arlt, Claudio Letizia, Marco Boscaro, Antonio Stigliano, Darko Kaštelan, Stylianos Tsagarakis, Shobana Athimulam, Uberto Pagotto, Uwe Maeder, Henrik Falhammar, John Newell‐Price, Massimo Terzolo, Martin Faßnacht - The Lancet Diabetes & Endocrinology 2022 cited by 181

  6. Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System

    Authors: , , , , , , - Frontiers in Endocrinology 2021 cited by 131

  7. Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Miomira Ivović, Massimo Terzolo, Darko Kastelan, William F. Young, Konstantinos N. Manolopoulos, Urszula Ambroziak, Dimitra A. Vassiliadi, Angela E. Taylor, Alice J. Sitch, Krishnarajah Nirantharakumar, Wiebke Arlt, ENSAT EURINE-ACT Investigators* - Annals of Internal Medicine 2022 cited by 136

  8. Combination Chemotherapy in Advanced Adrenocortical Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hanneke Wilmink, Monica Sender, Maureen Edgerly, W. Kenn, Tito Fojo, Hans‐Helge Müller, Britt Skogseid - New England Journal of Medicine 2012 cited by 864

  9. Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis

    Authors: , , , , , , , , , , , - European Journal of Endocrinology 2023 cited by 99

  10. Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cristina L. Ronchi, Bojana Simunov, Danae A. Delivanis, Robert P. Sutcliffe, Ioanna Tsirou, Tomasz Bednarczuk, Martín Reincke, Stephanie Burger‐Stritt, Richard A. Feelders, Letizia Canu, Harm R. Haak, Graeme Eisenhofer, Michael Conall Dennedy, Grethe Åstrøm Ueland, Miomira Ivovic, Antoine Tabarin, Massimo Terzolo, Marcus Quinkler, Darko Kastelan, Martin Fassnacht, Felix Beuschlein, Urszula Ambroziak, Dimitra A. Vassiliadi, Michael O’Reilly, William F. Young, Michael Biehl, Jonathan J Deeks, Wiebke Arlt, Stephan Glöckner, Richard Sinnott, Anthony Stell, Maria Candida Barisson Villares Fragoso, Darko Kastelan, Ivana D. Pupovac, Bojana Simunov, Sarah Cazenave, Magalie Haissaguerre, Antoine Tabarin, Jérôme Bertherat, Rossella Libé, Tina Kienitz, Marcus Quinkler, Katharina Langton, Graeme Eisenhofer, Felix Beuschlein, Christina Brugger, Martín Reincke, Anna Riester, Ariadni Spyroglou, Stephanie Burger‐Stritt, Timo Deutschbein, Martin Fassnacht, Stefanie Hahner, Matthias Kroiß, Cristina L. Ronchi, Sotiria Palimeri, Stylianos Tsagarakis, Ioanna Tsirou, Dimitra A. Vassiliadi, Vittoria Basile, Elisa Ingargiola, Giuseppe Reimondo, Massimo Terzolo, Letizia Canu, Massimo Mannelli, Hester Ettaieb, Harm R. Haak, Thomas Kerkhofs, Michael Biehl, Richard A. Feelders and 47 more - The Lancet Diabetes & Endocrinology 2020 cited by 247

  11. Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors

    Authors: , , , , , , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2011 cited by 456

  12. Major Prognostic Role of Ki67 in Localized Adrenocortical Carcinoma After Complete Resection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2015 cited by 335

  13. Adrenal Incidentalomas are Tied to Increased Risk of Diabetes: Findings from a Prospective Study

    Authors: , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2020 cited by 146

  14. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma

    Authors: , , , , , , , , , , - Cancer 2008 cited by 688

  15. Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2015 cited by 333

  16. Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2015 cited by 255

  17. Predictors of morbidity and mortality in acromegaly: an Italian survey

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Annamaria Colao, Massimo Terzolo, _ _ - European Journal of Endocrinology 2012 cited by 218

  18. THERAPY OF ENDOCRINE DISEASE: Improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing’s syndrome: a systematic review and meta-analysis

    Authors: , , , , , , , , , , - European Journal of Endocrinology 2016 cited by 165

  19. Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Svenja Nölting, Isabelle Bourdeau, Vasileios Chortis, Madeleine H. T. Ettaieb, Deborah Cosentini, Salvatore Grisanti, Eric Baudin, Paola Berchialla, Francesca Bovis, Maria Pia Sormani, Paolo Bruzzi, Felix Beuschlein, Jérôme Bertherat, Alfredo Berruti - The Lancet Diabetes & Endocrinology 2023 cited by 75

  20. Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study

    Authors: , , , , , , , , , - Frontiers in Endocrinology 2021 cited by 74

  21. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series

    Authors: , , , , , , , , , , , - Journal of Endocrinological Investigation 2006 cited by 713

  22. A Survey on Adrenal Incidentaloma in Italy1

    Authors: , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2000 cited by 268

  23. Prognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , - European Urology 2013 cited by 152

  24. AME Position Statement on adrenal incidentaloma

    Authors: , , , , , , , , , , , , , , , , - European Journal of Endocrinology 2011 cited by 512